[1] 毕晓飞,张俊文.不同时期使用生长抑素对预防ERCP术后胰腺炎及高淀粉酶血症的作用[J].重庆医学,2014,43(29):3885~3886,3889. [2] 吴莺.ENBD配合胃肠减压预防胆总管结石ERCP术后急性胰腺炎及高淀粉酶血症的临床护理[J].中西医结合护理(中英文),2015,1(3):73~75. [3] 孙海,吴国栋,张丰深,等.术后3h血清淀粉酶检测对ERCP术后胰腺炎的预测价值[J].肝胆胰外科杂志,2016,28(5):370~373,377. [4] Thiruvengadam N R, Forde K A, Chandrasekhara V, et al. Lowering the risk of post-ERCP pancreatitis[J].Gastrointest Endosc,2017, 85(3): 688~689. [5] 王艳静,许丙辉,台剑熊,等.血淀粉酶在生长抑素与硫酸镁辅助ERCP治疗急性胰腺炎前后的表达变化及意义[J].标记免疫分析与临床,2017,24(6):617~620. [6] 陈海东,韦良宏,宁琳,等.静脉滴注丹参注射液预防ERCP术后高淀粉酶血症及急性胰腺炎的临床研究[J].内科,2014,9(4):392~394. [7] 郭明文,艾耀伟,陈畅,等.生长抑素联合双氯芬酸钠对胆总管结石ERCP术后胰腺炎的预防作用[J].山东医药,2015,59(4):67~68. [8] 赵铭宁,杨勇,张文杰,等.ERCP后胰腺炎影响因素分析[J].肝胆胰外科杂志,2010,22(5):389~391,394. [9] Agerwala S M, Sundarapandiyan D, Weber G. Ketamine use for successful resolution of post-ERCP acute pancreatitis abdominal pain[J].Case Rep Anesthesiol,2017, 2017: 7845358. [10] 王艳静,许丙辉,台剑熊,等.生长抑素联合硫酸镁治疗ERCP术后急性胰腺炎临床效果及安全性分析[J].解放军医药杂志,2017,29(6):74~77. [11] 孙广正,施正超,戴华卫.ERCP后胰腺炎高危因素的回顾性研究[J].浙江创伤外科,2009,14(5):519~521. [12] Wang J, Su J, Lu Y, et al. A randomized control study to investigate the application of Ulinastatin-containing contrast medium to prevent post-ERCP pancreatitis[J].Hepatogastroenterology,2014, 61(136): 2391~2394. [13] Mariani A, Di Leo M, Giardullo N, et al. Early precut sphincterotomy for difficult biliary access to reduce post-ERCP pancreatitis: a randomized trial[J].Endoscopy,2016, 48(6): 530~535. [14] Testoni P A. Somatostatin: still a pharmaceutical defense weapon against post-ERCP pancreatitis? A 30-year story[J].Endoscopy,2015, 47(5): 393~395.
2018, Vol. 24 
冀公网安备13080202000677号